RamSoft and Therapixel Partner for AI Breast Imaging Integration
RamSoft and Therapixel have announced a commercial partnership to integrate Therapixel's AI-powered MammoScreen software into RamSoft's PowerServer and OmegaAI platforms, announced in a press release. This collaboration, revealed at the SIIM 2025 Annual Meeting, aims to provide seamless access to advanced AI capabilities for improved cancer detection and streamlined radiologist workflows.
The integration will allow RamSoft customers to use MammoScreen's AI-driven features directly within their existing systems. These features include pre-checks for image quality, comprehensive cancer detection analysis, and pre-reporting capabilities that reduce documentation time. Clinical studies have shown that MammoScreen can significantly enhance radiologist performance, increasing sensitivity and specificity while reducing reading and reporting times.
This partnership underscores the commitment of both companies to enhance diagnostic confidence and clinical productivity in breast imaging, offering a turnkey solution embedded within existing PACS workflows without the need for additional systems or interfaces.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
SimBioSys Gets FDA Clearance for AI Breast Cancer Recurrence Tool
AIRS Medical Gets FDA Clearance for MRI Body Composition Tool
Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
Sopris Capital Acquires Blackford Analysis from Bayer
Ember AI Launches Partner Program and Oracle Health Integration
Daily AI Brief: the AI news that matters, in your inbox.